SigurdisHaraldsdottirMDPhD

PubMed

• 1 citations
  Large Cancer Pedigree Involving Multiple Cancer Genes including Likely DigenicandLynch Syndrome (LS) and an Instance of Recombinational Rescue from LS.
  Ingrid P Vogelaar, Stephanie Greer, Fan Wang, GiWon Shin, Billy Lau, Yajing Hu, Sigurdis Haraldsdottir, Rocio Alvarez, Dennis Hazelett, Peter Nguyen, Francesca P Aguir...> ;Cancers. 2022 Dec 30
• Germline Testing for Individuals with Pancreatic Adenocarcinoma and Novel Genetic Risk Factors.
  Anu Chittenden, Sigurdis Haraldsdottir, Ethan Chen, Sahar Nissim> ;Hematology/oncology Clinics of North America. 2022 Oct 1
• 6 citations
  Implementation of a cloud-based electronic patient-reported outcome (ePRO) platform in patients with advanced cancer.
  Olga Generalova, Mohana Roy, Evan T. Hall, Sumit A. Shah, Kristen M. Cunanan, Touran Fardeen, Brianna Velazquez, Gilbert Chu, Bianca Bruzzone, Anna Cabot, George A. Fi...> ;Journal of Patient-Reported Outcomes. 2021 Sep 15
• 6 citations
  Profiling diverse sequence tandem repeats in colorectal cancer reveals co-occurrence of microsatellite and chromosomal instability involving Chromosome 8.
  GiWon Shin, Stephanie U. Greer, Erik S. Hopmans, Susan M. Grimes, Hojoon Lee, Lan Zhao, Laura Miotke, Carlos Suárez, Alison Almeda, Sigurdis Haraldsdottir, Hanlee P. Ji> ;Genome Medicine. 2021 Sep 6
• 17 citations
  Mismatch Repair (MMR) gene alteration and BRAF V600E mutation are potential predictive biomarkers of immune checkpoint inhibitors in MMR-deficient colorectal cancer
  Ibrahim Halil Sahin, Subir Goyal, Yoanna Pumpalova, Mohamad Bassam Sonbol, Satya Das, Sigurdis Haraldsdottir, Daniel H. Ahn, Kristen K. Ciombor, Zhengjia Chen, Jordan ...> ;The Oncologist. 2021 Aug 1
• 17 citations
  Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer
  Anu Chittenden, Sigurdis Haraldsdottir, Chinedu Ukaegbu, Meghan Underhill-Blazey, Shraddha Gaonkar, Hajime Uno, Lauren K. Brais, Kimberly Perez, Brian M. Wolpin, Sapna...> ;JCO Oncology Practice. 2021 Jan 13
• 26 citations
  Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications ...
  Satya Das, Kristen K. Ciombor, Sigurdis Haraldsdottir, Yoanna Pumpalova, Ibrahim Halil Sahin, Gino Pineda, Yu Shyr, Emily Pei Ying Lin, Chih-Yuan Hsu, Shih Kai Chu, La...> ;The Oncologist. 2020 Aug 1
• An amino-terminal BRAF deletion accounting for acquired resistance to RAF/EGFR inhibition in colorectal cancer.
  Jack K. Tung, Nastaran Neishaboori, Sigurdis Haraldsdottir, Carlos Suárez> ;Cold Spring Harbor Molecular Case Studies. 2020 Jul 15
• 4 citations
  Universal Screening of Gastrointestinal Malignancies for Mismatch Repair Deficiency at Stanford.
  Aser Abrha, Navika D. Shukla, Rachel Hodan, Teri A. Longacre, Shyam S. Raghavan, Colin C. Pritchard, George A. Fisher, James M. Ford, Sigurdis Haraldsdottir> ;JNCI Cancer Spectrum. 2020 Jun 19
• 13 citations
  Germline Testing for Patients With BRCA1/2 Mutations on Somatic Tumor Testing.
  Katherine Vlessis, Natasha Purington, Nicolette M. Chun, Sigurdis Haraldsdottir, James M. Ford> ;JNCI Cancer Spectrum. 2020 Feb 1
• 166 citations
  Genetic/Familial high-risk assessment: Colorectal, version 2.2019 featured updates to the NCCN guidelines
  Samir Gupta, Dawn Provenzale, Xavier Llor, Amy L. Halverson, William Grady, Daniel C. Chung, Sigurdis Haraldsdottir, Arnold J. Markowitz, Thomas P. Slavin, Heather Ham...> ;Journal of the National Comprehensive Cancer Network. 2019 Sep 1
• 5 citations
  Comparison of definitive chemoradiation with 5-fluorouracil versus capecitabine in anal cancer.
  Yoanna Pumpalova, Margaret M. Kozak, Rie von Eyben, Pamela L. Kunz, George A. Fisher, Daniel T. Chang, Sigurdis Haraldsdottir> ;Journal of Gastrointestinal Oncology. 2019 Aug 1
• 14 citations
  Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon Cancer.
  Julie L. Koenig, Diego A.S. Toesca, Jeremy P. Harris, Chiaojung Jillian Tsai, Sigurdis Haraldsdottir, Albert Lin, Erqi L. Pollom, Daniel T. Chang> ;American Journal of Clinical Oncology. 2019 Jul 1
• "Histology of colorectal adenocarcinoma with double somatic mismatch-repair mutations is indistinguishable from those caused by Lynch syndrome"-reply.
  Rachel Pearlman, Jessica Hemminger, Heather Hampel, Wendy L Frankel> ;Human Pathology. 2019 Jul 1
• 8 citations
  Methylated SEPTIN9 plasma test for colorectal cancer detection may be applicable to Lynch syndrome
  Megan P. Hitchins, Ingrid P Vogelaar, Kevin Brennan, Sigurdis Haraldsdottir, Nianmin Zhou, Brock A. Martin, Rocio Alvarez, Xiaopu Yuan, Sungjin Kim, Maha Guindi, Andre...> ;BMJ Open Gastroenterology. 2019 May 1
• 58 citations
  Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome.
  Rachel Pearlman, Sigurdis Haraldsdottir, Albert de la Chapelle, Jon G. Jonasson, Sandya Liyanarachchi, Wendy L. Frankel, Thorunn Rafnar, Kari Stefansson, Colin C. Prit...> ;Journal of Medical Genetics. 2019 Mar 14
• 8 citations
  Tumor Molecular Testing Guides Anti‐PD‐1 Therapy and Provides Evidence for Pathogenicity of Mismatch Repair Variants
  Shyam A. Patel, Teri A. Longacre, Uri Ladabaum, Alexandra Lebensohn, Albert Lin, Sigurdis Haraldsdottir> ;The Oncologist. 2018 Dec 1
• 20 citations
  Targeting BRAF Mutations in High-Grade Neuroendocrine Carcinoma of the Colon.
  Jarred Burkart, Dwight H. Owen, Manisha H. Shah, Sherif Abdel-Misih, Sameek Roychowdhury, Robert Wesolowski, Sigurdis Haraldsdottir, Julie W. Reeser, Eric Samorodnitsk...> ;Journal of the National Comprehensive Cancer Network. 2018 Sep 1
• 10 citations
  Histology of colorectal adenocarcinoma with double somatic mismatch-repair mutations is indistinguishable from those caused by Lynch syndrome.
  Jessica A Hemminger, Rachel Pearlman, Sigurdis Haraldsdottir, Deborah Knight, Jon Gunnlaugur Jonasson, Colin C Pritchard, Heather Hampel, Wendy L Frankel> ;Human Pathology. 2018 Aug 1
• 1 citations
  The risk of developing a mismatch repair deficient colorectal cancer after undergoing cholecystectomy.
  Matthías Halldórsson, Michael Hauptmann, Petur Snaebjornsson, Kristín Huld Haraldsdóttir, Thor Aspelund, Elias F. Gudmundsson, Vilmundur Gudnason, Jon G. Jonasson, Sig...> ;Scandinavian Journal of Gastroenterology. 2018 Jul 16
• 1 citations
  Phase I Trial of Dabrafenib and Pazopanib in BRAF Mutated Advanced Malignancies
  Sigurdis Haraldsdottir, Filip Janku, Ming Poi, Cynthia Timmers, Susan Geyer, Larry J. Schaaf, Jennifer Sexton, Lai Wei, Jennifer Thurmond, Vivianne Velez-Bravo, Vanda ...> ;JCO Precision Oncology. 2018 May 14
• 40 citations
  Promising New Agents for Colorectal Cancer
  Satya Das, Kristen K. Ciombor, Sigurdis Haraldsdottir, Richard M. Goldberg> ;Current Treatment Options in Oncology. 2018 May 11
• 31 citations
  Management of Borderline Resectable Pancreatic Cancer.
  Diego A.S. Toesca, A. Koong, George A. Poultsides, Brendan C. Visser, Sigurdis Haraldsdottir, Albert C. Koong, Daniel T. Chang> ;International Journal of Radiation Oncology, Biology, Physics. 2018 Apr 1
• 10 citations
  Microsatellite Instability Testing Using Next-Generation Sequencing Data and Therapy Implications
  Sigurdis Haraldsdottir> ;JCO Precision Oncology. 2017 Oct 3
• 81 citations
  Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2
  Sigurdis Haraldsdottir, Thorunn Rafnar, Wendy L. Frankel, Sylvia Einarsdottir, Asgeir Sigurdsson, Heather Hampel, Petur Snaebjornsson, Gisli Masson, Daniel Weng, Reyni...> ;Nature Communications. 2017 May 3
• Join now to see all